INSIGHTS ON QUALITY CONTROL
-
Which X-Ray, Metal Detector, Or Checkweigher Is Right For Your Industry?
Navigate the complexities of pharmaceutical safety with a guide to tailored inspection systems. Match the right technology to your specific product format for total compliance and quality.
-
Improving Bioprocess Monitoring And Control With Multivariate Data Analysis
Learn about multivariate data analysis (MVDA) techniques, like PCA and PLS, that enable near real-time monitoring, prediction, and optimization of biomanufacturing processes.
-
High-Throughput Pyrogen Testing In A Multimode Microplate Reader
Explore a faster, high‑sensitivity approach to pyrogen detection that uses an NF‑κB reporter system to measure both endotoxin and non‑endotoxin contaminants to enable shorter workflows.
-
Quantitative Determination Of Amorphous And Crystalline Drug In Polymer Microspheres
Biodegradable polymer microspheres control drug release through crystalline and amorphous properties, analyzed using DSC, MDSC, and TGA to determine composition and stability for precise delivery.
-
Maintaining A State Of Control: EM And DES In Biopharma4/9/2026
Partner with a proven team to streamline your facility validation and environmental monitoring programs with flexible, cGMP-compliant services and reliable on-site collection.
-
Quality Assurance In Pharmaceutical Water For Injection (WFI) Systems3/19/2026
Maintaining the integrity of Water for Injection (WFI) systems is a non-negotiable priority in pharmaceutical manufacturing. Watch this webinar to refine your contamination control strategies.
-
Manufacturing Solutions3/4/2025
Explore a cutting-edge service in powder blending, encapsulation, tablet compression, and on-site laboratory testing that meets the highest standards to ensure exceptional quality and compliance with cGMP regulations.
-
Seamlessly Integrating An E-WorkBook With A Customer's LIMS8/12/2024
Explore the story of a global biopharma company's integration of E-WorkBook with their LIMS, automating ADA study reports, saving significant time, and enhancing data accuracy.
-
Optimizing End-To-End Contract Analytical Support For Cell And Gene Therapies7/11/2024
The development and production of CGTs presents unparalleled complexities. Learn how a partner with robust end-to-end services can help you overcome challenges at every step of the drug lifecycle.
QUALITY CONTROL SOLUTIONS
-
Wearable technologies that allow for dosing of high-volume biologics over a longer time need to be designed with manufacturability end-user needs in mind and must comply with the highest quality and regulatory standards.
-
Advance organizational expertise with structured training designed for technical mastery. Explore specialized lessons that empower teams to optimize complex workflows and maintain compliance.
-
Traditional bioburden testing (or microbial limit testing) takes several days to grow visible colonies of microorganisms, so identifying these and initiating corrective action takes longer. The Milliflex® Quantum system quantitatively detects microbial contamination in filterable samples in as little as a third of the time it takes with traditional plate-based monitoring methods. The Milliflex® Quantum system is based on fluorescent staining of all viable microorganisms, making emerging microcolonies visible to the system when they’re still too small to be seen with the naked eye. After rapid detection, the colonies can be reincubated to grow into visible colonies and be identified by any method—an approach that cleverly combines rapid and compendial bioburden testing.
-
As the only major supplier worldwide, we offer all three media to test for Mycoplasma according to EP 2.6.7 and USP 63 as both broth and agar plates. These ready-to-use Friis, Frey, and Hayflick culture media help to make the cumbersome compendial procedures of testing cell cultures, raw materials, intermediates, and final products for mycoplasmas easier.
-
Learn how the flexible non-GMP environment of our laboratories supports quick adjustments to formulations, dosage forms, and delivery systems without extensive revalidation.